| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 22/06/23 | 07:00:08 | 22 Jun 2023 | RNA Medicine Shows In Vitro Anti-Cancer Efficacy | RNS | |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | Antibody Program Results & Orphan Drug Indication | RNS | |
| 13/06/23 | 12:00:01 | 13 Jun 2023 | Result of AGM | RNS | |
| 13/06/23 | 07:00:12 | 13 Jun 2023 | Anti-Cancer MDK mRNA - Positive in vitro Results | RNS | |
| 12/06/23 | 07:48:42 | 12 Jun 2023 | Updated dial-in details for AGM | RNS | |
| 07/06/23 | 10:11:46 | 7 Jun 2023 | Restoration of Trading | RNS | |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | Notice of Annual General Meeting | RNS | |
| 06/06/23 | 07:00:04 | 6 Jun 2023 | Gold & Silver Processing Update | RNS | |
| 05/06/23 | 07:00:07 | 5 Jun 2023 | Annual Report & Financial Statements - 31 Dec 2022 | RNS | |
| 19/05/23 | 07:00:04 | 19 May 2023 | Notice of AGM | RNS | |
| 18/05/23 | 07:00:05 | 18 May 2023 | Final Results | RNS | |
| 02/05/23 | 07:56:14 | 2 May 2023 | Suspension of Trading Pending 2022 Annual Report | RNS | |
| 30/03/23 | 07:00:04 | 30 Mar 2023 | Operational Update | RNS | |
| 13/03/23 | 07:30:04 | 13 Mar 2023 | Confirmation of No Exposure to Silicon Valley Bank | RNS | |
| 08/03/23 | 07:00:06 | 8 Mar 2023 | Creation of New Novel Family of mRNA Therapeutics | RNS | |
| 06/03/23 | 07:00:02 | 6 Mar 2023 | Formation of Scientific Advisory Board | RNS | |
| 01/03/23 | 07:00:12 | 1 Mar 2023 | Company Presentation | RNS | |
| 27/02/23 | 15:30:02 | 27 Feb 2023 | Holding(s) in Company | RNS | |
| 24/02/23 | 14:05:48 | 24 Feb 2023 | Second Price Monitoring Extn | RNS | |
| 24/02/23 | 14:00:30 | 24 Feb 2023 | Price Monitoring Extension | RNS | |
| 21/02/23 | 07:00:08 | 21 Feb 2023 | Investor Presentation | RNS | |
| 20/02/23 | 07:00:03 | 20 Feb 2023 | Randox Licence and Royalty Agreement | RNS | |
| 17/02/23 | 14:05:38 | 17 Feb 2023 | Second Price Monitoring Extn | RNS | |
| 17/02/23 | 14:00:10 | 17 Feb 2023 | Price Monitoring Extension | RNS | |
| 15/02/23 | 15:00:01 | 15 Feb 2023 | Holding(s) in Company | RNS | |
| 07/02/23 | 07:00:03 | 7 Feb 2023 | Operations Update | RNS | |
| 30/01/23 | 16:00:01 | 30 Jan 2023 | Grant of Share Options | RNS | |
| 27/01/23 | 16:15:01 | 27 Jan 2023 | Holding(s) in Company | RNS | |
| 25/01/23 | 15:00:01 | 25 Jan 2023 | Holding(s) in Company | RNS | |
| 24/01/23 | 07:00:03 | 24 Jan 2023 | MDK Oncology Antibodies Demonstrate In-Vivo Safety | RNS | |
| 20/01/23 | 12:40:01 | 20 Jan 2023 | Holding(s) in Company | RNS | |
| 20/01/23 | 12:40:01 | 20 Jan 2023 | Total Voting Rights | RNS | |
| 18/01/23 | 08:36:18 | 18 Jan 2023 | Holding(s) in Company | RNS | |
| 17/01/23 | 11:05:38 | 17 Jan 2023 | Second Price Monitoring Extn | RNS | |
| 17/01/23 | 11:00:35 | 17 Jan 2023 | Price Monitoring Extension | RNS | |
| 17/01/23 | 09:05:31 | 17 Jan 2023 | Second Price Monitoring Extn | RNS | |
| 17/01/23 | 09:00:21 | 17 Jan 2023 | Price Monitoring Extension | RNS | |
| 17/01/23 | 07:00:06 | 17 Jan 2023 | Placing and Appointment of Joint Broker | RNS | |
| 16/01/23 | 07:00:06 | 16 Jan 2023 | Appointment of Auditor | RNS | |
| 09/01/23 | 07:00:01 | 9 Jan 2023 | Operations Update | RNS | |
| 05/01/23 | 07:00:05 | 5 Jan 2023 | Operations Update | RNS | |
| 13/12/22 | 13:30:01 | 13 Dec 2022 | Director/PDMR Shareholding | RNS | |
| 08/12/22 | 15:21:03 | 8 Dec 2022 | Director/PDMR Shareholding | RNS | |
| 05/12/22 | 08:07:52 | 5 Dec 2022 | Presentation of Midkine Oligonucleotide Program | RNS | |
| 01/12/22 | 14:00:06 | 1 Dec 2022 | Resignation of Auditor | RNS | |
| 09/11/22 | 07:00:04 | 9 Nov 2022 | Mineral Resource Estimate | RNS | |
| 31/10/22 | 11:06:02 | 31 Oct 2022 | Second Price Monitoring Extn | RNS | |
| 31/10/22 | 11:00:48 | 31 Oct 2022 | Price Monitoring Extension | RNS | |
| 25/10/22 | 16:42:00 | 25 Oct 2022 | Second Price Monitoring Extn | RNS | |
| 25/10/22 | 16:36:55 | 25 Oct 2022 | Price Monitoring Extension | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 22/06/23 | 07:00:08 | 22 Jun 2023 | RNA Medicine Shows In Vitro Anti-Cancer Efficacy | RNS | |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | Antibody Program Results & Orphan Drug Indication | RNS | |
| 13/06/23 | 12:00:01 | 13 Jun 2023 | Result of AGM | RNS | |
| 13/06/23 | 07:00:12 | 13 Jun 2023 | Anti-Cancer MDK mRNA - Positive in vitro Results | RNS | |
| 12/06/23 | 07:48:42 | 12 Jun 2023 | Updated dial-in details for AGM | RNS | |
| 07/06/23 | 10:11:46 | 7 Jun 2023 | Restoration of Trading | RNS | |
| 06/06/23 | 07:00:08 | 6 Jun 2023 | Notice of Annual General Meeting | RNS | |
| 06/06/23 | 07:00:04 | 6 Jun 2023 | Gold & Silver Processing Update | RNS | |
| 05/06/23 | 07:00:07 | 5 Jun 2023 | Annual Report & Financial Statements - 31 Dec 2022 | RNS | |
| 19/05/23 | 07:00:04 | 19 May 2023 | Notice of AGM | RNS | |
| 18/05/23 | 07:00:05 | 18 May 2023 | Final Results | RNS | |
| 02/05/23 | 07:56:14 | 2 May 2023 | Suspension of Trading Pending 2022 Annual Report | RNS | |
| 30/03/23 | 07:00:04 | 30 Mar 2023 | Operational Update | RNS | |
| 13/03/23 | 07:30:04 | 13 Mar 2023 | Confirmation of No Exposure to Silicon Valley Bank | RNS | |
| 08/03/23 | 07:00:06 | 8 Mar 2023 | Creation of New Novel Family of mRNA Therapeutics | RNS | |
| 06/03/23 | 07:00:02 | 6 Mar 2023 | Formation of Scientific Advisory Board | RNS | |
| 01/03/23 | 07:00:12 | 1 Mar 2023 | Company Presentation | RNS | |
| 27/02/23 | 15:30:02 | 27 Feb 2023 | Holding(s) in Company | RNS | |
| 24/02/23 | 14:05:48 | 24 Feb 2023 | Second Price Monitoring Extn | RNS | |
| 24/02/23 | 14:00:30 | 24 Feb 2023 | Price Monitoring Extension | RNS | |
| 21/02/23 | 07:00:08 | 21 Feb 2023 | Investor Presentation | RNS | |
| 20/02/23 | 07:00:03 | 20 Feb 2023 | Randox Licence and Royalty Agreement | RNS | |
| 17/02/23 | 14:05:38 | 17 Feb 2023 | Second Price Monitoring Extn | RNS | |
| 17/02/23 | 14:00:10 | 17 Feb 2023 | Price Monitoring Extension | RNS | |
| 15/02/23 | 15:00:01 | 15 Feb 2023 | Holding(s) in Company | RNS | |
| 07/02/23 | 07:00:03 | 7 Feb 2023 | Operations Update | RNS | |
| 30/01/23 | 16:00:01 | 30 Jan 2023 | Grant of Share Options | RNS | |
| 27/01/23 | 16:15:01 | 27 Jan 2023 | Holding(s) in Company | RNS | |
| 25/01/23 | 15:00:01 | 25 Jan 2023 | Holding(s) in Company | RNS | |
| 24/01/23 | 07:00:03 | 24 Jan 2023 | MDK Oncology Antibodies Demonstrate In-Vivo Safety | RNS | |
| 20/01/23 | 12:40:01 | 20 Jan 2023 | Holding(s) in Company | RNS | |
| 20/01/23 | 12:40:01 | 20 Jan 2023 | Total Voting Rights | RNS | |
| 18/01/23 | 08:36:18 | 18 Jan 2023 | Holding(s) in Company | RNS | |
| 17/01/23 | 11:05:38 | 17 Jan 2023 | Second Price Monitoring Extn | RNS | |
| 17/01/23 | 11:00:35 | 17 Jan 2023 | Price Monitoring Extension | RNS | |
| 17/01/23 | 09:05:31 | 17 Jan 2023 | Second Price Monitoring Extn | RNS | |
| 17/01/23 | 09:00:21 | 17 Jan 2023 | Price Monitoring Extension | RNS | |
| 17/01/23 | 07:00:06 | 17 Jan 2023 | Placing and Appointment of Joint Broker | RNS | |
| 16/01/23 | 07:00:06 | 16 Jan 2023 | Appointment of Auditor | RNS | |
| 09/01/23 | 07:00:01 | 9 Jan 2023 | Operations Update | RNS | |
| 05/01/23 | 07:00:05 | 5 Jan 2023 | Operations Update | RNS | |
| 13/12/22 | 13:30:01 | 13 Dec 2022 | Director/PDMR Shareholding | RNS | |
| 08/12/22 | 15:21:03 | 8 Dec 2022 | Director/PDMR Shareholding | RNS | |
| 05/12/22 | 08:07:52 | 5 Dec 2022 | Presentation of Midkine Oligonucleotide Program | RNS | |
| 01/12/22 | 14:00:06 | 1 Dec 2022 | Resignation of Auditor | RNS | |
| 09/11/22 | 07:00:04 | 9 Nov 2022 | Mineral Resource Estimate | RNS | |
| 31/10/22 | 11:06:02 | 31 Oct 2022 | Second Price Monitoring Extn | RNS | |
| 31/10/22 | 11:00:48 | 31 Oct 2022 | Price Monitoring Extension | RNS | |
| 25/10/22 | 16:42:00 | 25 Oct 2022 | Second Price Monitoring Extn | RNS | |
| 25/10/22 | 16:36:55 | 25 Oct 2022 | Price Monitoring Extension | RNS |